Agel Introduces New Probiotic Product for Digestive Health
29 Sep, 2015, 04:18 ET
DALLAS, Sept. 29, 2015 /PRNewswire/ -- Agel Enterprises, a member of the CVSL Inc. [NYSE MKT: CVSL] family of consumer brands, has introduced a new probiotic product in gel form that it believes represents an important advance in this category of supplements.
The product is called Agel BIO™ and it delivers probiotic strains through a water-based suspension gel. This is expected to ensure that the benefits of the supplement are delivered more effectively and spread more evenly in the intestine than is the case with probiotic pills or capsules, according to microbiologist Kiran Krishnan, whose company was involved in the development of the product.
"Agel BIO is one of the most exciting advances in probiotics that I've seen in my career," said Krishnan. "It is designed to maintain a healthy balance of good and bad bacteria within the body, and that in turn promotes proper digestion, absorption of nutrients from food and overall good health and a sense of well-being."
Probiotics are live bacteria and yeasts that many studies have shown are good for human digestive health. They are naturally found in the body. Agel BIO uses two different probiotic strains that work together once absorbed by the body.
"One of the keys to a healthy body is having the right balance of good and bad bacteria in the digestive system. Agel BIO is a fantastic product with an amazingly efficient delivery system, because it is in gel form. I believe it represents an important advance in this vital area of good health," said Krishnan.
Agel BIO was introduced at Agel's tenth annual sales convention, in Lyon, France. "Within hours of our introducing the product, our entire initial stock had been sold out," commented Jeff Higginson, Agel's co-CEO. "We've been developing cutting edge supplements for ten years, and Agel BIO is a great breakthrough to launch our second decade."
CVSL is a growing platform of direct-to-consumer brands. Within CVSL, each company retains its own separate brand identity, sales force and compensation plan. CVSL companies currently include The Longaberger Company, a 42-year old maker of hand-crafted baskets and other home decor items; Your Inspiration At Home, an award-winning maker of hand-crafted spices and other gourmet food items from around the world; Tomboy Tools, a direct seller of tools designed for women as well as home security systems; Agel Enterprises, a global seller of nutritional products in gel form as well as a skin care line, operating in 40 countries; Paperly, which offers a line of custom stationery and other personalized products; My Secret Kitchen, a U.K.-based seller of gourmet food products; Uppercase Living, which offers an extensive line of customizable vinyl expressions for display on walls in the home; and Kleeneze, a UK-based seller of cleaning, health, beauty, home, outdoor and a variety of other products. CVSL also includes Happenings, a lifestyle publication and marketing company.
Cautionary Note Regarding Forward-Looking Statements:
This press release contains forward-looking statements that involve risks and uncertainties. All statements other than statements of historical fact contained in this press release are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipate," "believe," "can," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," or "will" or the negative of these terms or other comparable terminology. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements include statements about the growth of CVSL, the expected benefits of the product and the impact of the new probiotic product on the supplements market. These statements are subject to a number of risks and uncertainties, including the customer demand for the products, risks related to the sale of nutritional supplements generally and the risks outlined under "Risk Factors" in CVSL's Annual Report on Form 10-K/A for its fiscal year ended December 31, 2014 and those risks discussed in other documents we file with the Securities and Exchange Commission, which may cause our actual results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements to differ materially from expectations. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this press release to conform our statements to actual results or changed expectations.
CVSL Media Contact: Russell Mack ([email protected])
CVSL Investor Relations Contact: Tucker Gagen ([email protected])
SOURCE CVSL Inc.
Share this article